ketoconazole has been researched along with Dysgammaglobulinemia in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Dysgammaglobulinemia: An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.
| Excerpt | Relevance | Reference |
|---|---|---|
| " She was treated continuously for 6 years with ketoconazole at the same dosage of 200 mg/day." | 5.28 | Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. ( Dompmartin, A; Houtteville, JP; Leroy, D; Theron, J, 1989) |
| " She was treated continuously for 6 years with ketoconazole at the same dosage of 200 mg/day." | 1.28 | Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. ( Dompmartin, A; Houtteville, JP; Leroy, D; Theron, J, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coovadia, HM | 1 |
| Hamed, Z | 1 |
| Bayles, MA | 1 |
| Kiepiela, P | 1 |
| Leroy, D | 1 |
| Dompmartin, A | 1 |
| Houtteville, JP | 1 |
| Theron, J | 1 |
2 other studies available for ketoconazole and Dysgammaglobulinemia
| Article | Year |
|---|---|
Chronic mucocutaneous candidiasis with IgA deficiency in a two-year-old African girl who responded well to ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Child, Preschool; Dysgammaglobulinemia; Facial Derm | 1983 |
Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole.
Topics: Adult; Aneurysm, Infected; Candidiasis; Candidiasis, Chronic Mucocutaneous; Dose-Response Relationsh | 1989 |